JP2020512309A - ロイコトリエン受容体拮抗薬のバイオアベイラビリティの改善のための処理方法及び装置 - Google Patents
ロイコトリエン受容体拮抗薬のバイオアベイラビリティの改善のための処理方法及び装置 Download PDFInfo
- Publication number
- JP2020512309A JP2020512309A JP2019548270A JP2019548270A JP2020512309A JP 2020512309 A JP2020512309 A JP 2020512309A JP 2019548270 A JP2019548270 A JP 2019548270A JP 2019548270 A JP2019548270 A JP 2019548270A JP 2020512309 A JP2020512309 A JP 2020512309A
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- film
- oral
- montelukast
- film layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762478876P | 2017-03-30 | 2017-03-30 | |
US62/478,876 | 2017-03-30 | ||
PCT/CA2018/050389 WO2018176149A1 (en) | 2017-03-30 | 2018-03-29 | Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2020512309A true JP2020512309A (ja) | 2020-04-23 |
Family
ID=63673863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019548270A Pending JP2020512309A (ja) | 2017-03-30 | 2018-03-29 | ロイコトリエン受容体拮抗薬のバイオアベイラビリティの改善のための処理方法及び装置 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3600265A1 (de) |
JP (1) | JP2020512309A (de) |
KR (1) | KR20190128637A (de) |
CN (1) | CN110381931A (de) |
AU (1) | AU2018241534A1 (de) |
BR (1) | BR112019018388A2 (de) |
CA (1) | CA3056944A1 (de) |
MX (1) | MX2019010573A (de) |
WO (1) | WO2018176149A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3150213A1 (en) * | 2018-09-14 | 2022-03-19 | Intelgenx Corp. | TREATMENT METHOD AND DEVICE FOR ENHANCED BIOAVAILABILITY OF MONTELUKAST, A LEUCOTRIEN RECEPTOR ANTAGONIST |
US20210393611A1 (en) * | 2018-11-05 | 2021-12-23 | Intelgenx Corp. | Lipophilic active oral film formulation and method of making the same |
US11602504B2 (en) * | 2018-11-05 | 2023-03-14 | Intelgenx Corp. | Lipophilic active oral film formulation and method of making the same |
CN110496124A (zh) * | 2019-04-10 | 2019-11-26 | 中山大学附属第五医院 | 治疗脉管畸形的化合物 |
CN114931578A (zh) * | 2022-05-16 | 2022-08-23 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | 孟鲁司特在制备用于治疗***性红斑狼疮药物中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101074271B1 (ko) * | 2009-06-25 | 2011-10-17 | (주)차바이오앤디오스텍 | 불쾌한 맛을 효과적으로 은폐한 경구용 속용 필름 |
KR101077468B1 (ko) * | 2011-03-04 | 2011-11-07 | (주)차바이오앤디오스텍 | 안정한 경구용 속용 필름 제제 |
EA038558B1 (ru) * | 2013-10-14 | 2021-09-14 | Зим Лэбораториз Лимитед | Водорастворимая фармацевтическая пленка с повышенной стабильностью |
US9668970B2 (en) * | 2013-12-02 | 2017-06-06 | Intelgenx Corp. | Film dosage form with extended release mucoadhesive particles |
CN104784157B (zh) * | 2015-04-04 | 2018-06-26 | 齐鲁制药有限公司 | 一种稳定的孟鲁司特口腔薄膜剂 |
-
2018
- 2018-03-29 JP JP2019548270A patent/JP2020512309A/ja active Pending
- 2018-03-29 AU AU2018241534A patent/AU2018241534A1/en not_active Abandoned
- 2018-03-29 BR BR112019018388A patent/BR112019018388A2/pt not_active Application Discontinuation
- 2018-03-29 MX MX2019010573A patent/MX2019010573A/es unknown
- 2018-03-29 EP EP18774366.1A patent/EP3600265A1/de not_active Withdrawn
- 2018-03-29 KR KR1020197025967A patent/KR20190128637A/ko unknown
- 2018-03-29 WO PCT/CA2018/050389 patent/WO2018176149A1/en unknown
- 2018-03-29 CA CA3056944A patent/CA3056944A1/en active Pending
- 2018-03-29 CN CN201880016281.6A patent/CN110381931A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2018241534A1 (en) | 2019-09-26 |
CA3056944A1 (en) | 2018-10-04 |
KR20190128637A (ko) | 2019-11-18 |
EP3600265A1 (de) | 2020-02-05 |
CN110381931A (zh) | 2019-10-25 |
MX2019010573A (es) | 2019-10-24 |
BR112019018388A2 (pt) | 2020-04-07 |
WO2018176149A1 (en) | 2018-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020512309A (ja) | ロイコトリエン受容体拮抗薬のバイオアベイラビリティの改善のための処理方法及び装置 | |
JP2019531310A (ja) | 神経炎症と関連した病態を処置するためのデバイス及び方法 | |
US20220395452A1 (en) | Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists | |
US20230201130A1 (en) | Lipophilic active oral film formulation and method of making the same | |
JP2008508255A (ja) | モダフィニル経口凍結乾燥物 | |
WO2011110939A2 (en) | Pharmaceutical compositions of substituted benzhydrylpiperazines | |
US20180116976A1 (en) | Methods and compositions for unwanted or abnormal muscle contractions | |
KR20110015445A (ko) | 아미노시클로헥산 유도체 및 시클로덱스트린의 복합체를 포함하는 제약 조성물 | |
AU2015389109B2 (en) | Enteric-coated pellets containing a proton pump inhibitor | |
US20220362164A1 (en) | Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists | |
JP2024009146A (ja) | 医薬活性化合物の苦味抑制剤及び苦味抑制方法 | |
JP7482532B2 (ja) | サイクロセリン化合物の製剤およびそれらの用途 | |
KR101555908B1 (ko) | 몬테루카스트 또는 이의 약제학적으로 허용 가능한 염을 포함하는 액상 제제 및 이의 제조방법 | |
EP3849553A1 (de) | Behandlungsverfahren und vorrichtung zur verbesserten bioverfügbarkeit von montelukast, einem leukotrienrezeptorantagonist | |
CA3017526A1 (en) | Method of treatment and device for the improved bioavailability of leukotriene receptor antagonists | |
US20210393611A1 (en) | Lipophilic active oral film formulation and method of making the same | |
JP2011068614A (ja) | ビタミン製剤 | |
Bhai | Taste Masking of Fluoroquinolone Antibiotics by Microencapsulation Preparation and Evaluation of Oral Suspension |